Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation, A Randomized Double-blind and Vehicle-Controlled Study

NCT03926845 is registered in ClinicalTrials.gov with Institute of Dermatology, Thailand as lead sponsor.

NCT NCT03926845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03926845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Tolerability of an Isobutylamido-thiazolyl-resorcinol Cream 0.2% for Facial Hyperpigmentation, A Randomized Double-blind and Vehicle-Controlled Study
Lead sponsor
Institute of Dermatology, Thailand
Phase
Not applicable
Overall status
Completed
Start date
April 29, 2019
Completion date
January 31, 2021
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

facial hyperpigmentation